文献速递免疫规划

Quil-A®佐剂免疫绵羊可拓宽抗肝片形吸虫MF6p/FhHDM-1抗原的抗体谱,联合免疫可损害虫体生长与抗原释放

Vaccination of sheep with Quil-A® adjuvant expands the antibody repertoire to the Fasciola MF6p/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes.
PubMed 文献 · Vaccine · 2018-03-08

本研究在绵羊中探讨TH1极化佐剂Quil-A®对MF6p/FhHDM-1蛋白免疫应答的影响及天然与合成蛋白的抗肝片形吸虫病疫苗潜力。单用Quil-A®皮下注射可拓宽后续囊蚴初次感染触发的抗MF6p/FhHDM-1抗体谱,氢氧化铝无此效果;合成蛋白加Quil-A®免疫使攻击感染后抗体应答延迟2-4周,虫体生长受阻且抗原释放低。

要点

  • 单用Quil-A®皮下注射可拓宽绵羊初次感染囊蚴后抗MF6p/FhHDM-1的抗体谱。
  • 氢氧化铝佐剂未观察到对MF6p/FhHDM-1抗体谱的类似拓宽效果。
  • 合成MF6p/FhHDM-1加Quil-A®免疫使攻击感染后抗体应答延迟2-4周。

核心结论

  • Quil-A®佐剂可拓宽绵羊对MF6p/FhHDM-1的抗体谱,合成蛋白加Quil-A®免疫可干扰肝片形吸虫生长与抗原释放,但未证明与TH1免疫应答相关事件有关。

研究设计与样本

  • 绵羊实验研究:比较Quil-A®单用与氢氧化铝对MF6p/FhHDM-1抗体谱的影响,并评估天然与合成MF6p/FhHDM-1加Quil-A®的疫苗潜力。

主要发现

  • 单用Quil-A®皮下注射(不共注射抗原)可拓宽后续囊蚴初次感染触发的抗MF6p/FhHDM-1抗体谱,氢氧化铝无此效果。
  • 合成MF6p/FhHDM-1加Quil-A®免疫使攻击实验感染后绵羊抗体应答延迟2-4周。
  • 建立的虫体种群生长受阻且抗原释放低,可能因代谢活性降低。
  • 上述效应未证明与TH1免疫应答相关事件(IgG2同型抗体产生和IFN-γ)有关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fasciolosis continues to be a major cause of economic losses in the livestock industry and a growing threat to humans. The limited spectrum of effective anthelmintics and the appearance of resistances urge the need for developing an effective vaccine. Most studies have been focused on the use of TH1-polarizing adjuvants and the use of recombinant Fasciola critical molecules and, despite the efforts, no reproducible protections have been achieved. The F. hepatica MF6p/FhHDM-1 protein is a heme-binding protein also reported to have immunomodulatory properties, constituting a promising target for vaccination and/or as target for the development of new flukicides. Thus, in this study, we investigated the effects of the TH1-polarizing adjuvant Quil A® on sheep immune response to MF6p/FhHDM-1, and the vaccine potential of both native and synthetic forms of this protein against ovine fasciolosis. Subcutaneous injection of Quil A® alone, i.e., without co-injecting any antigen, expands the antibody repertoire to MF6p/FhHDM-1 triggered by a subsequent primoinfection with metacercariae. This effect was not observed with aluminum hydroxide, the most frequently adjuvant used in commercial vaccines. On the other hand, vaccination with synthetic MF6p/FhHDM-1 in Quil A® prompted a 2-4-week delay in the antibody response induced in sheep by a challenge experimental infection. Moreover, fluke populations stablished showed stunted growth and low antigen release probably due to reduced metabolic activity. These observations suggest that primary circulating antibodies induced by the immunization had harmful effects on fluke development. Such effects could not be demonstrated to be associated to TH1 immune response linked events (production of IgG2 isotype antibodies and IFN-γ).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Orbegozo-Medina RA, Martínez-Sernández V, González-Warleta M, et al. Vaccination of sheep with Quil-A® adjuvant expands the antibody repertoire to the Fasciola MF6p/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes. Vaccine. 2018. PMID: 29525280. doi:10.1016/j.vaccine.2018.02.115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。